Post-market Follow Up Study on Paragon CRT® 100 (Paflufocon D)
Clinical trial NCT04187599 · RECRUITING
Trial details
- NCT number
- NCT04187599
- Sponsor
- CooperVision International Limited (CVIL)
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2019-08-29
- Primary completion
- 2020-11-30
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.